Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 2/20 | 0.33 |
| ▸ | NPC1 | O15118 | 2/20 | 0.33 |
| ▸ | RAB9A | P51151 | 2/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | RECQL | P46063 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 2/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.32 |
| ▸ | NTSR1 | P30989 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | MAOB | P27338 | 2/20 | 0.32 |
| ▸ | MAOA | P21397 | 1/20 | 0.32 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.30 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.30 |
| ▸ | RELA | Q04206 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20845248 | 0.97 | MAPT (0.33) | MAPTNPC1RAB9ASMN1; SMN2LMNA | |
| SCHEMBL20845092 | 0.93 | HPGD (0.34) | MAPTSMN1; SMN2LMNAMEN1KMT2A | |
| SCHEMBL20845250 | 0.92 | ALDH1A1 (0.36) | MAPTSMN1; SMN2LMNAMEN1KMT2A | |
| SCHEMBL20222819 | 0.90 | MAPT (0.36) | MAPTNPC1RAB9ASMN1; SMN2LMNA | |
| SCHEMBL20845056 | 0.89 | MAPT (0.34) | MAPTNPC1RAB9ASMN1; SMN2LMNA | |
| SCHEMBL20845242 | 0.88 | SMN1; SMN2 (0.34) | MAPTNPC1RAB9ASMN1; SMN2LMNA | |
| SCHEMBL20845241 | 0.88 | MEN1 (0.39) | MAPTNPC1RAB9ASMN1; SMN2LMNA | |
| SCHEMBL20845087 | 0.88 | DHODH (0.37) | MAPTNPC1RAB9ASMN1; SMN2KMT2A | |
| SCHEMBL20845088 | 0.88 | DHODH (0.34) | MAPTNPC1RAB9ASMN1; SMN2KMT2A | |
| SCHEMBL20222678 | 0.87 | MAPT (0.37) | MAPTNPC1RAB9ASMN1; SMN2LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190092745-A1 | COMPOUND AND ORGANIC ELECTRONIC DEVICE USING THE SAME | NICHEM FINE TECHNOLOGY CO., LTD. (TW) | 2019-03-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190092745-A1 | COMPOUND AND ORGANIC ELECTRONIC DEVICE USING THE SAME | SCO2, AOX1, ORC3 | MAPT 4294/4885NPC1 4683/4885RAB9A 635/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.